Company / Income Tax per Share
Travere Therapeutics, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
-$0.00 / $0.01
FY2021-FY2025
Trend
+609.6%
vs FY2024
Sector context
#77 of 201
Health Care
What the data says
Income Tax per Share changed +610% YoY in FY2025, a notable deviation from the 9-year average annual change of +167%.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -9.7%.
Increased from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +31.1%
- 5-Year CAGR
- -9.7%
- 10-Year CAGR
- -
Sector benchmark
#125 of 201 in Health CareTop 62% of 201This company $0.01 Sector average $1.35
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 609.6% year-over-year.
- Ranks #77 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2019.
- Lowest income tax per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +609.6% |
| FY2024 | $0.00 | -54.1% |
| FY2023 | $0.00 | -30.7% |
| FY2022 | $0.01 | +1346.2% |
| FY2021 | -$0.00 | -102.1% |
| FY2020 | $0.02 | -43.1% |
| FY2019 | $0.03 | +113.4% |
| FY2018 | -$0.25 | +20.8% |
| FY2017 | -$0.31 | -360.3% |
| FY2016 | -$0.07 | +85.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026